20143 ⎘
Medicinal preparations characterised by special physical form; Preparations in capsules, e.g. of gelatin, of chocolate; Filling excipients; Inactive ingredients Compounds of unknown constitution, e.g. material from plants or animals
Compositions and methods for treating severe pain
#302Eukaryotic microorganisms for producing lipids and antioxidants
#303Abrasion-Resistant Opioid Formulations
#304Pharmaceutical Formulation Containing Gelling Agent
#305Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#306Steroidal Compositions
#307High-strength testosterone undecanoate compositions
#308Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption
#309Cholesterol lowering capsules
#310STERODIAL COMPOSITIONS
#311High-strength testosterone undecanoate compositions
#312Liquid phospholipid-containing compositions for the preparation of pharmaceuticals
#313Capsules containing high doses of krill phospholipids
#314Composition of Olivetol and Method of Use to Reduce or Inhibit the Effects of Tetrahydrocannabinol in the Human Body
#315Composition of olivetol and method of use to reduce or inhibit the effects of tetrahydrocannabinol in the human body
#316Solubilized CoQ-10
#317Solubilized CoQ-10
#318Pharmaceutical formulation containing gelling agent
#319Fumarate ester dosage forms
#320Fumarate ester pharmaceutical compositions
#321Oral dosage forms of bendamustine
#322Stable dosage form articles for oral administration
#323Composition that relieves heartburn, GERD and hangovers
#324Extracts of and formulations and uses thereof
#325Fumarate ester pharmaceutical compositions
#326Pharmaceutical dosage form for immediate release of an indolinone derivative
#327Fast acting joint relief formulations
#328Abuse resistant capsule
#329ORALLY ADMINISTERED AGENT FOR RUMINANTS AND RUMINANT FEED CONTAINING SAME
#330HYALURONIC ACID AND/OR SALT THEREOF, METHOD FOR PRODUCING SAME, AND FOOD, COSMETIC, AND PHARMACEUTICAL CONTAINING SAID HYALURONIC ACID AND/OR SALT THEREOF
#331Abuse-resistant drug formulations
#332Method of freeze-drying encapsulated cells, freeze-dried encapsulated cells, compositions containing freeze-dried encapsulated cells and uses of such cells and compositions
#333Capsule containing total flavonoids of desmodium styracifolium, method for preparing the same and use
#334Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
#335Compositions for colonic delivery of drugs
#336Composition containing reduced coenzyme Qand production method thereof
#337Abuse-deterrent opioids
#338Fumarate ester pharmaceutical compositions
#339Fumarate ester pharmaceutical compositions
#340Carbidopa/levodopa gastroretentive drug delivery
#341Formulations and compositions of vitamin D analogs for treating and preventing cancer and other diseases
#342Methods for purifying trans-(−)-Δ-tetrahydrocannabinol and trans- (+)-Δ-tetrahydrocannabinol
#343Methods for purifying trans-(−)-Δ-tetrahydrocannabinol and trans-(+)-Δ-tetrahydrocannabinol
#344Methods for reducing the occurrence of hot flashes
#345Reduction type coenzyme Q10 powder, composition thereof, and preparation method thereof
#346Pharmaceutical preparations
#347High-strength testosterone undecanoate compositions
#348Lactobacillus plantarum capsule for poultry and use thereof
#349Fast acting joint relief formulations
#350Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
#351MANUFACTURE OF PEANUT FORMULATIONS FOR ORAL DESENSITIZATION
#352Hard capsule formulation
#353ALL-NATURAL ENTERIC SOFT CAPSULES COMPRISING ACTIVE INGREDIENTS
#354LIQUID-FILLED IMMEDIATE RELEASE SOFT GELATIN CAPSULES
#355Drug for killing acid-fast (red) bacillus
#356Compositions and methods for preventing and recovery from detrimental effects of alcohol consumption
#357Oral Dosage Forms of Bendamustine
#358Pharmaceutical composition having reduced abuse potential
#359Combination therapeutics and methods for the treatment of neurodegenerative and other diseases
#360Opioid abuse-deterrent controlled release formulations
#361Abuse-deterrent controlled release formulations
#362Compositions of Antioxidants and Oil for an antioxidant paste or supplement or liquid or frozen product
#363Controlled release fumarate esters
#364Composition with increased bioavailability of orally administered embryo-peptides and process for its obtainment
#365High-strength testosterone undecanoate compositions
#366Eukaryotic microorganisms for producing lipids and antioxidants
#367SOLUBILIZED COQ-10
#368ORAL CAFFEINE DELIVERY COMPOSITION
#369Multi-carotenoids compositions and uses therefor
#370Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin D2 and 25-hydroxyvitamin D3
#371Konjac formulation and method for preparing the same
#372COMPOSITIONS FOR COMBINED IMMEDIATE AND SUSTAINED RELEASE OF CANNABINOIDS, METHODS OF MANUFACTURE AND USE THEREOF
#373Testosterone undecanoate compositions
#374Methods and compositions for treating diabetes
#375CARBIDOPA/LIPODOPA GASTRORETENTIVE DRUG DELIVERY
#376Protease inhibitor-containing compositions, compositions comprising same, and methods for producing and using same
#377COMPOSITIONS COMPRISING SUGAR-CYSTEINE PRODUCTS
#378Carbidopa/levodopa gastroretentive drug delivery
#379High-strength testosterone undecanoate compositions
#380Manufacture of peanut formulations for oral desensitization
#381Abuse resistant capsule
#382Cycloalkyl-substituted imidazole derivative
#383Pharmaceutical semi-solid composition of isotretinoin
#384CAPSULES COMPRISING AN EMULSIFIED SYRUP AND METHODS OF MAKING THE SAME
#385Method for manufacturing phosphonocrotonic acid derivative
#386Modulation of solubility, stability, absorption, metabolism, and pharmacokinetic profile of lipophilic drugs by sterols
#387Abuse and alcohol resistant drug composition
#388Eukaryotic microorganisms for producing lipids and antioxidants
#389Medical compositions, methods of making and using those compositions, and kits including those compositions
#390Cycloalkyl-Substituted Imidazole Derivative
#391Formulations and dosage forms of oxidized phospholipids
#392Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
#393Liquid-filled hard gel capsule pharmaceutical formulations
#394soft capsule for reducing fat and losing weight and preparation method thereof
#395Method for inhibition of blood phosphorus level elevation
#396COMPOSITION AND METHOD FOR TREATING ULCERS
#397Compositions and Methods for Treating Pain
#398Cycloalkyl-substituted imidazole derivative
#399Steroidal compositions
#400Use of hydroxyprogesterone derivatives for enhancing health and physical performance
#401High-strength testosterone undecanoate compositions
#402SUBSTANCES FOR REDUCING OCCURRENCE OF MAJOR CARDIAC EVENTS IN HUMANS
#403METHOD FOR PRODUCING REDUCED COENZYME Q10, METHOD FOR STABILIZING SAME, AND COMPOSITION COMPRISING SAME
#404Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#405TESTOSTERONE UNDECANOATE COMPOSITIONS
#406High-Strength Testosterone Undecanoate Compositions
#407Solubilized CoQ-10
#408Solubilized CoQ-10
#409Pharmaceutical formulation containing gelling agent
#410Pharmaceutical composition for diabetic nephropathy and its preparation and application
#411Soft capsule of butylphthalide and a process for preparing the same
#412Formulation of silibinin with high efficacy and prolonged action and the preparation method thereof
#413Oral Dosage Forms Of Bendamustine
#414Tocotrienol Compositions
#415Compositions that include anthocyanidins and methods of use
#416MODULATION OF SIDE EFFECT PROFILE OF 5-ALPHA REDUCTASE INHIBITOR THERAPY
#417Antibiotic Formulations Providing Reduced Gastrointestinal Side Effects and Clostridium difficile Infection Relapse, and Related Methods
#418MODULATION OF SOLUBILITY, STABILITY, ABSORPTION, METABOLISM, AND PHARMACOKINETIC PROFILE OF LIPOPHILIC DRUGS BY STEROLS
#419Lipoic acid pellet composition
#420Carbidopa/Levodopa gastroretentive drug delivery
#421SYNERGISTIC COMPOSITION OF (-)-HYDROXYCITRIC ACID WITH MONOTERPENE AND A METHOD TO ENHANCE SATIETY
#422ORAL PHARMACEUTICAL PARICALCITOL FORMULATIONS
#423INHIBITOR FOR BLOOD PHOSPHORUS LEVEL ELEVATION
#424COMPOSITION FOR TREATMENT OF ISCHEMIC HEART DISEASE, FACILITATION OF BLOOD CIRCULATION AND ANGIOGENESIS, IMPROVING SKIN BEAUTY, IMPROVING MALE SEXUAL FUNCTION CONTAINING GINSENG BERRY EXTRACT
#425PHARMACEUTICAL COMPOSITION FOR DIABETIC NEPHROPATHY AND ITS PREPARATION AND APPLICATION
#426PHARMACEUTICAL COMPOSITION FOR DIABETIC NEPHROPATHY AND ITS PREPARATION AND APPLICATION
#427PRODUCT AND USE OF OMEGA-3S MATCHING HUMAN TISSUE RATIOS FOR TREATMENT OF INFLAMMATORY AND OTHER CONDITIONS
#428Steroidal compositions
#429Pharmaceutical formulation containing gelling agent
#430Monoacetyldiacylglycerol Derivative for the Treatment of Sepsis
#431NOVEL COMPOSITION BASED ON CHOLEST-4-EN-3-ONE OXIME
#432DRIED FORMULATIONS
#433GELATIN CAPSULES COMPRISING AN ACID
#434o/w/o EMULSION CONTAINING LIGNAN COMPOUNDS AND COMPOSITION CONTAINING THE SAME
#435ENCAPSULATION OF HEAT AND MOISTURE SENSITIVE SUBSTANCES
#436Tamibarotene capsule preparation
#437Multi-carotenoids compositions and methods
#438Treating vitamin D insufficiency and deficiency with 25-hydroxyvitamin Dand 25-hydroxyvitamin D
#439Pharmaceutical composition
#440Methods for purifying trans-(−)-Δ-tetrahydrocannabinol and trans-(+)-Δ-tetrahydrocannabinol
#441Compositions for the encapsulation of natural product extracts in oil medium in hard gelatin capsules and a method of encapsulation
#442Multi-carotenoids compositions and uses therefor
#443Pharmaceutical composition having reduced abuse potential
#444Methods of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
#445Reduced coenzyme Q10-containing composition comprising a surfactant which is stable against oxidation and method for stabilization by mixing with surfactant(s)
#446NOVEL FENOFIBRATE FORMULATIONS AND RELATED METHODS OF TREATMENT
#447USE OF GARLIC OIL TO INCREASE BIOAVAILABILITY OF COENZYME Q-10
#448Eukaryotic Microorganisms for producing lipids and antioxidants
#449Abuse Resistant and Extended Release Formulations and Method of Use Thereof
#450Pharmaceutical composition containing gelling agent
#451Compositions containing Mg/Zn/F-CaP plus inhibitors of pro-inflammatory cytokines (alpha ketoalkanoic acid compound) for osteoporosis prevention, therapy and treatment of bone diseases
#452BUTYLPHTHALIDE SOFT GEL CAPSULE AND ITS PREPARATION PROCEDURE
#453Substances for Reducing Occurence of Major Cardiac Events in Humans
#454LOQUAT COMPOSITIONS
#455Tissue Factor Production Inhibitor
#456Monoacetyldiacylglycerol derivative for the treatment of sepsis
#457Compositions containing coenzyme Q-10 and dihydrolipoic acid
#458ATOMOXETINE FORMULATIONS AND ASSOCIATED METHODS
#459Composition and method for treating or preventing gastrointestinal cancer
#460METHOD, FORMULATION, AND USE THEREOF FOR IMPROVED ORAL ABSORPTION OF PHARMACEUTICALS OR NUTRIENTS
#461Composition containing reduced coenzyme Q10 and production method thereof
#462Butylphtualide Soft Gel Capsule and Its Preperation Procedure
#463Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
#464MULTI-CAROTENOIDS COMPOSITIONS AND USES THEREFOR
#465Coenzyme Q10 Formulation and Process Methodology for Soft Gel Capsules Manufacturing
#466DPP IV inhibitors
#467Kiwi extract
#468SOFTGEL CAPSULES
#469Oral composition a first composition (a) and a second composition (b) as a combination product for separate or consecutive administration in the cosmetic treatment of the human body
#470Inhibition of tissue damage to skin from radiation treatment therapy
#471Composition and method for issue repair and regeneration
#472Soft capsule of butylphthalide and a process for preparing the same
#473Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency
#474Method of making and using theaflavin, theaflavin-3-gallate, theaflavin-3′-gallate and theaflavin 3,3′-digallate and mixtures thereof
#475Methods and compositions for oral administration of proteins
#476Encapsulated energy gel compositions
#477Formulations for hyperforin-enriched hypericum fractions
#478Method for preventing ulceration or irritation of mucosa
#479for the enhancement of urogenital health
#480Room-temperature stable dronabinol formulations
#481CONTROLLED RELEASE PREPARATION
#482Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing
#483Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene
#484DPP IV inhibitors
#485Solubilized CoQ-10
#486Solubilized CoQ-10
#487Oral brexanolone compositions and methods of preparation and use
#488Method and system for reducing active ingredient potency in pain-management compositions to a quarter amount of approved levels
#489Capsule with internal diaphragm for improved bioavailability
#490Process of making stable abuse-deterrent oral formulations